University Of North Carolina, Chapel Hill
Clinical trials sponsored by University Of North Carolina, Chapel Hill, explained in plain language.
-
Can a diabetes drug curb chronic Pouch-Related bathroom trips?
Disease control Not yet recruitingThis trial tests whether tirzepatide (Zepbound) can reduce daily bowel frequency in adults with an ileal pouch-anal anastomosis (IPAA) who have chronic high bowel frequency despite standard anti-diarrheal therapy. Participants will be assigned to receive tirzepatide or standard c…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Digital coaching may curb binge eating in black women with obesity
Disease control Not yet recruitingThis study tests a 6-month digital program that combines appetite awareness training with behavioral weight loss techniques, delivered remotely via Zoom. It aims to help Black women with obesity who binge eat at least once a week relearn hunger cues and prevent weight gain. The t…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for EoE patients? drug trial targets those failed by steroids
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already used for other conditions, can help adults with eosinophilic esophagitis (EoE) who still have symptoms despite using topical steroids. Over 12 weeks, 52 participants will take either upadacitinib or a placebo, then all will re…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for kids with cashew allergy: daily drops may build tolerance
Disease control Not yet recruitingThis study tests a treatment called sublingual immunotherapy (SLIT) for children ages 1-11 with cashew allergy. For 18 months, children receive daily drops under the tongue to see if they can safely eat more cashew without a reaction. The goal is to reduce allergy severity, not c…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could treating the whole family stop malaria in pregnancy?
Prevention Not yet recruitingThis pilot study tests whether giving a malaria drug (dihydroartemisinin piperaquine) to household members of pregnant women can help prevent malaria in the mothers. About 300 participants in Uganda will receive either a single dose or monthly doses. The goal is to see if this ap…
Phase: EARLY_PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
New study tests whether extra support during pregnancy can prevent early delivery
Prevention Not yet recruitingThis study tests a personalized support program called PTBCARE+ for pregnant individuals at high risk of delivering early. The program includes a stress reduction toolkit, a website/app, care coordination, and optional massage. Researchers will compare stress levels and birth out…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Could an arthritis drug stop asthma attacks in their tracks?
Symptom relief Not yet recruitingThis pilot study tests whether anakinra, a drug that reduces inflammation, can help people with moderate asthma attacks. 60 adults at high risk for asthma attacks will either receive anakinra or a placebo at home when they feel an attack starting. The study will check if this app…
Phase: PHASE1 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New study tests mindfulness breathing for chronic cough relief
Symptom relief Not yet recruitingThis early-stage study will test if a brief, breath-focused therapy called Acceptance and Commitment Therapy (ACT) is practical and safe for adults with chronic cough. Researchers will enroll 30 people to see if they can stick with the program and find it helpful. The goal is to …
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis study tests whether medications that calm mast cells (ketotifen and cromolyn) can safely reduce persistent symptoms like fatigue, pain, and brain fog in people who had a tick-borne illness. Fifty adults aged 21-65 will receive either one of these drugs or a standard antihist…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Fish oil pills tested as new hope for jaw pain sufferers
Symptom relief Not yet recruitingThis study tests whether a special omega-3 supplement can reduce pain in adults with chronic temporomandibular disorder (TMD), a condition causing jaw pain. One hundred participants will take either the supplement or a placebo daily for 8 weeks. Researchers will measure changes i…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Food label showdown: can warnings beat stars for healthier shopping?
Knowledge-focused Not yet recruitingThis study compares two types of food labels to see which one better helps Indonesian adults spot unhealthy products. Researchers will show 1,000 participants either a nutrient warning label or the Nutri-Level label and test their ability to identify foods high in sugar, salt, or…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Could exercise be a new way to clear lungs in PCD?
Knowledge-focused Not yet recruitingThis study looks at how exercise and a saltwater mist (hypertonic saline) affect mucus clearance in people with primary ciliary dyskinesia (PCD), a rare lung condition where tiny hairs in the airways don't work properly. Researchers will measure how fast the lungs clear inhaled p…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Which cannabis warnings stick? study puts messages to the test
Knowledge-focused Not yet recruitingThis study aims to find out which cannabis warning messages are most effective at raising awareness and changing perceptions. Researchers will show US adults (both users and non-users) seven different warning messages covering topics like dependence, cognitive function, and cardi…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Colombia study tests if warning labels outsmart cartoon characters on junk food
Knowledge-focused Not yet recruitingThis study looks at how packaging with warning labels and cartoon characters influences what Colombian teens aged 12 to 17 think about buying and eating ultraprocessed foods. About 1,960 teens will view different product images online and answer questions about how likely they ar…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New study aims to curb Post-Surgery opioid overprescribing
Knowledge-focused Not yet recruitingThis study tests whether a training program helps surgeons and hospital staff reduce the number of opioid painkillers they prescribe after surgery. About 40 healthcare workers and patient representatives from hospitals in North Carolina will take part. The goal is to see if the p…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Teen brain study: can hormone pills calm suicide risk?
Knowledge-focused Not yet recruitingThis study looks at how natural hormone changes during the menstrual cycle may make some teenage girls more irritable or depressed, especially those at risk for suicide. Researchers will give 50 girls ages 12-16 either a birth control pill to keep hormones steady or a placebo for…
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a 6-Week program boost Parents' confidence with teens?
Knowledge-focused Not yet recruitingThis study tests a 6-week virtual parenting program called AMP-CARE for parents of teens aged 11-14. It aims to see if the program improves parents' confidence and knowledge about teen mental health. 60 parents will be randomly assigned to take the program right away or later. Th…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC